Topic: Breast cancer
Document Owner: Head of Evidence and Quality Hub, National Cancer Control Programme (NCCP)
National Group: National Cancer Control Programme
Effective From: 13 November 2025
Unfortunately, you are using an outdated browser. Please, upgrade your browser to improve your experience with HSE. The list of supported browsers:
The purpose of this National Clinical Guideline is to provide evidence-based recommendations on safe and effective treatment of patients with breast cancer using radiotherapy, maximising clinical effectiveness and minimising harm to patients.